IQVIA Holdings Inc. has announced a strategic partnership with NVIDIA to develop custom foundation models and agentic AI workflows aimed at accelerating research, clinical development, and access to new treatments in the life sciences sector. This collaboration will leverage IQVIA's vast healthcare-specific data alongside NVIDIA's advanced technology to enhance and streamline clinical trials and commercial launches through powerful workflow coordination and insights. The new AI agents, unveiled at GTC Paris, are designed to transform business processes and improve patient outcomes by using NVIDIA's NIM Agent Blueprints, NeMo Customizer, and NeMo Guardrails for rapid development and secure deployment. This partnership highlights a pivotal opportunity for both companies to push the frontier of AI in healthcare, promising smarter solutions for the industry.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。